comparemela.com

Latest Breaking News On - Hoc analyses - Page 1 : comparemela.com

Text Messages With Financial Incentives for Men With Obesity

This randomized clinical trial assesses whether text messaging combined with financial incentives or text messages alone could help men with obesity lose

United kingdomCity ofGlasgow cityPat hoddinottHealth economics research unitNational institute for health researchNational institute of healthHealth technology assessmentHealth action processSchool for primary care research fundingUnited kingdom office for national statisticsStirling universityScientist officeScotland research ethics committeeNational research scotland primary care networkOffice for national statistics

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial | Coronavirus (COVID-19) | JAMA

This randomized clinical trial compares the effects of 3 doses of bamlanivimab monotherapy (700 vs 2800 vs 7000 mg) vs combination bamlanivimab and etesevimab v

United statesEteläuomen läiJunshi biosciencesBristol myers squibbDanielm skovronskyEli lillyMonte carloVan naardenDavid mcilwainAbcellera biologicsDrug administrationInstitute incWorld health organizationInfectious diseases vaccine research centerGilead sciencesNational institute of allergy

Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial | JAMA

This randomized trial assesses the comparative effectiveness of direct oral anticoagulants vs low-molecular-weight heparin on rate of 6-month recurrence of veno

Memorial sloan kettering cancer centerNew yorkUnited statesGenentech rocheQuinn johnstonAstellas pharmaDeborah schragAlliance foundation trialsCovington burlingBlood instituteBristol myers squibbAlliance for clinical trials in oncologyOutcomes research instituteDrug administrationNational institutes of healthOr foundation

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial | Infectious Diseases | JAMA

This open-label randomized trial compares the effect of remdesivir (5 or 10 days) vs standard care on clinical status 11 days after treatment initiation among p

United statesEteläuomen läiSoriano viladomiuLe turnierGlaxosmithkline viiBristol meyers squibbDianam brainardSanyal bioGroup informationEuropean medicines agencyBoehringer ingelheimLaboratory monitoringEuropean medicines agency for europeInstitute incNational institute of allergyDrug administration for the united states

Neurocrine Biosciences Presents Data on Treatment of Patients with Congenital Adrenal Hyperplasia at ECE 2023

/PRNewswire/ Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today announced that it will present new.

United kingdomNorthern irelandNeurocrine biosciencesEiryw robertsPrnewswire neurocrine biosciences incDiurnal ltdEuropean commissionHealthcare products regulatory agencyRegulatory agencyDiurnal groupEuropean commission for the economic areaEuropean congressDrug administrationNeurocrine biosciences incPost hoc analysesAndrogen reduction across

vimarsana © 2020. All Rights Reserved.